![](/img/cover-not-exists.png)
LentiGlobin gene therapy for transfusion-dependent β-Thalassemia: Update from the northstar HGB-204 phase 1/2 clinical study
Rasko, J., Thompson, A., Kwiatkowski, J., Hongeng, S., Schiller, G.J., Anurathapan, U., Cavazzana-Calvo, M., Ho, P., von Kalle, C., Kletzel, M., Leboulch, P., Vichinsky, E., Petrusich, A., Asmal, M.,Volume:
19
Language:
english
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2017.02.033
Date:
May, 2017
File:
PDF, 79 KB
english, 2017